Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De-escalated chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma
2019-003058-10Phase 2Active
- Sponsor
- Východoslovenský onkologický ústav
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by Východoslovenský onkologický ústav. Primary endpoint: Two-year locoregional control. Started Sep 2019; status: active.
02
Drugs
cisplatin
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on 2019-003058-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003058-10.